{"url_path":"/sec/ptct/8-k/2026-06-09/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1070081/0001104659-26-071916-index.html","accession_number":"0001104659-26-071916","cik":"0001070081","ticker":"PTCT","issuer_name":"PTC THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1070081/0001104659-26-071916-index.html","primary_entity_key":"0001070081","primary_entity_name":"PTC THERAPEUTICS, INC."},"word_count":107,"has_tables":true,"body_markdown":"**Item 9.01. Financial Statements and Exhibits.**\n\n(d) Exhibits\n\n​\n\n​\n\n​\n\n**Exhibit No.**\n\n  ​ ​ ​\n\n**Description**\n\n10.1\n\n​\n\n[Consulting Services Agreement between the Registrant and Alethia Young](tmb-20260608xex10d1.htm)\n\n104\n\n​\n\nThe cover page from this Current Report on Form 8-K, formatted in Inline XBRL\n\n​\n\n​\n\n​\n\n​\n\n**SIGNATURE**\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n​\n\n​\n\n​\n\n​\n\n**PTC Therapeutics, Inc.**\n\n​\n\n​\n\nDate: June 9, 2026\n\nBy:\n\n/s/ Pierre Gravier\n\n​\n\nName:\n\nPierre Gravier\n\n​\n\nTitle:\n\nChief Financial Officer\n\n​\n\n​"}